- Home
- DBI vs IMRX Comparison
DBI vs IMRX Comparison
Compare DBI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- IMRX
- Stock Information
- Founded
- DBI 1991
- IMRX 2008
- Country
- DBI United States
- IMRX United States
- Employees
- DBI N/A
- IMRX N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- IMRX Health Care
- Exchange
- DBI Nasdaq
- IMRX Nasdaq
- Market Cap
- DBI 151.8M
- IMRX 145.7M
- IPO Year
- DBI 1991
- IMRX 2021
- Fundamental
- Price
- DBI $3.30
- IMRX $4.06
- Analyst Decision
- DBI Hold
- IMRX Strong Buy
- Analyst Count
- DBI 2
- IMRX 4
- Target Price
- DBI $3.50
- IMRX $13.25
- AVG Volume (30 Days)
- DBI 1.5M
- IMRX 922.9K
- Earning Date
- DBI 09-10-2025
- IMRX 08-05-2025
- Dividend Yield
- DBI 6.06%
- IMRX N/A
- EPS Growth
- DBI N/A
- IMRX N/A
- EPS
- DBI N/A
- IMRX N/A
- Revenue
- DBI $2,949,575,000.00
- IMRX N/A
- Revenue This Year
- DBI N/A
- IMRX N/A
- Revenue Next Year
- DBI $2.45
- IMRX N/A
- P/E Ratio
- DBI N/A
- IMRX N/A
- Revenue Growth
- DBI N/A
- IMRX N/A
- 52 Week Low
- DBI $2.18
- IMRX $1.00
- 52 Week High
- DBI $8.45
- IMRX $4.69
- Technical
- Relative Strength Index (RSI)
- DBI 60.67
- IMRX 59.69
- Support Level
- DBI $2.67
- IMRX $3.95
- Resistance Level
- DBI $3.51
- IMRX $4.69
- Average True Range (ATR)
- DBI 0.20
- IMRX 0.36
- MACD
- DBI 0.07
- IMRX -0.09
- Stochastic Oscillator
- DBI 75.00
- IMRX 27.62
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.